March 25, 2007
Audio Journal of Cardiovascular Medicine Rapid Genotype Assay for Individualized Warfarin Dosing REFERENCE: Abstract 1020-89, American College of Cardiology New Orleans JEFFREY ANDERSON, University of Utah, Salt Lake City COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis The hope of refining treatments for cardiovascular disease by genotyping patients to detect individual sensitivities to particular medical therapies was brought a step closer at the ACC meeting in New Orleans by results from a study using a rapid genothype test. Jeffrey Anderson told Peter Goodwin about the assay they've been investigating which indicates required dosing of warfarin.
